Company registration number 15190303 (England and Wales)
JMJ DIAGNOSTICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH REGISTRAR
JMJ DIAGNOSTICS LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 4
JMJ DIAGNOSTICS LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2024
31 October 2024
- 1 -
2024
Notes
£
£
Fixed assets
Tangible assets
3
1,794
Current assets
Cash at bank and in hand
4,994
Creditors: amounts falling due within one year
4
(2,064)
Net current assets
2,930
Net assets
4,724
Capital and reserves
Called up share capital
100
Profit and loss reserves
4,624
Total equity
4,724
For the financial period ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 4 June 2025
Mr M Murphy
Director
Company registration number 15190303 (England and Wales)
JMJ DIAGNOSTICS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 OCTOBER 2024
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 5 October 2023
-
Period ended 31 October 2024:
Profit and total comprehensive income
-
5,624
5,624
Issue of share capital
100
-
100
Dividends
-
(1,000)
(1,000)
Balance at 31 October 2024
100
4,624
4,724
JMJ DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2024
- 3 -
1
Accounting policies
Company information
JMJ Diagnostics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Simpkins Edwards LLP, The Summit, Woodwater Park, Pynes Hill, Exeter, EX2 5WS.
1.1
Reporting period
The company incorporated on 5 October 2023 and the first financial statements cover the period from this date to the accounting reference date of 31 October 2024. Due to this the financial statements present a period longer than one year and there are no comparative amounts presented in the financial statements (including the related notes). Future comparative amounts (including the related notes) may also not be entirely comparable.
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
20% on net book value
Fixtures and fittings
15% on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Taxation
The tax expense represents the sum of the tax currently payable.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
JMJ DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2024
- 4 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2024
Number
Total
1
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 5 October 2023
Additions
1,929
At 31 October 2024
1,929
Depreciation and impairment
At 5 October 2023
Depreciation charged in the period
135
At 31 October 2024
135
Carrying amount
At 31 October 2024
1,794
4
Creditors: amounts falling due within one year
2024
£
Trade creditors
186
Taxation and social security
910
Other creditors
968
2,064